Zoloft Tablets

Zoloft is a brand name for sertraline, a selective serotonin reuptake inhibitor (SSRI) supplied here as oral tablets. The main decision on this page is between the 25 mg, 50 mg and 100 mg strengths and the package quantities we currently offer. The prescribed strength comes first; package size and price can then be compared within that strength.

Our smallest available quantity depends on the strength selected. We offer 25 mg tablets in quantities starting at 90 tablets, 50 mg tablets from 60 tablets and 100 mg tablets from 30 tablets. Larger quantities are available up to 360 tablets. This makes it important to compare the options for the prescribed strength rather than assuming that every strength comes in the same packages.

Comparing price and package value

Our prices vary by both strength and quantity. The comparison below shows the current package options, exact prices in pounds sterling, per-tablet value and relative savings available from us. It provides the detailed figures without relying on external pharmacy prices, market averages or unsupported discount claims.

Per-tablet cost is useful for comparing packages of the same prescribed strength, but it is only one part of the decision. A larger package does not automatically represent better practical value. It may be unsuitable when the dose is being reviewed, the intended supply is shorter, or there is uncertainty about whether treatment will continue unchanged.

Before choosing a quantity, consider how many tablets the prescriber intends to be supplied, whether a review is due and whether the medicine can be stored correctly for the full period. The lowest unit price should not override those clinical and practical factors.

Strength and quantity choices

The three offered strengths contain the same active ingredient and use the same oral tablet form, but they are not interchangeable tablet for tablet. Changing from one strength to another can alter the dose unless the number of tablets is adjusted under appropriate medical direction. Select the strength stated by the prescriber rather than choosing according to package price or availability.

Sertraline treatment may involve dose adjustments, but the appropriate starting dose, subsequent dose and timing of any change depend on the indication and the individual. A 25 mg tablet may be used where a lower tablet strength is required, while 50 mg and 100 mg tablets provide other prescribed strengths. Their presence in our catalogue does not indicate which dose is suitable for a particular person.

• Check that the strength matches the current prescribing instructions.
• Compare quantities only within that prescribed strength.
• Account for any planned review before selecting a longer supply.
• Do not combine or divide tablets to create a different dose unless the prescriber or dispensing instructions specifically allow it.

What should influence the package quantity?

The most useful quantity is generally the one that corresponds to the authorised supply and expected treatment period without creating unnecessary surplus. A smaller quantity may be more appropriate while tolerability or dose is being assessed. A larger quantity may be practical for stable treatment when it matches the intended supply, but a lower per-tablet price alone is not a medical reason to choose it.

Storage and expiry also matter. Tablets should remain in suitable packaging, be protected from moisture and be used within their labelled shelf life. Buying more than can reasonably be used may cancel out any apparent unit-value advantage.

When comparing our packages, check:

• the prescribed tablet strength and number of tablets;
• the expected date of the next clinical or medication review;
• whether the dose has recently changed or may soon be reassessed;
• the total package price as well as the per-tablet figure; and
• whether the full quantity can be stored appropriately and used before expiry.

Brand and generic context

Zoloft is a brand name, while sertraline is the active ingredient. Generic sertraline tablets contain the same active ingredient but may come from different manufacturers and can differ in appearance, inactive ingredients, package presentation and authorised product information. A catalogue brand name should therefore not be treated as proof that every sertraline product is identical in all respects.

Brand availability and marketing authorisations can also vary by country. The supplied regional information does not confirm that Zoloft 25 mg, 50 mg or 100 mg tablets are currently authorised under that brand in the United Kingdom. Customers who need to verify the exact UK product and marketing-authorisation holder can consult the MHRA Products database or ask an appropriate healthcare professional.

Other SSRIs and other classes of antidepressant are separate medicines rather than package alternatives for Zoloft. A medicine such as fluoxetine, paroxetine, citalopram or escitalopram should not be substituted for sertraline without a prescriber's decision, even if it is used for a similar condition.

Established uses of sertraline

Sertraline is used in adults for depression and several anxiety-related or trauma-related conditions. Established adult indications include depression, obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD) and social anxiety disorder. The exact authorised indications can depend on the particular product information.

In children and adolescents, its established use is narrower. Sertraline may be used for OCD in those aged 6 to 17 years, with age-appropriate dosing and careful monitoring. Its adult indications should not be assumed to apply automatically to every person under 18.

NHS guidance describes sertraline as an SSRI used for depression and certain anxiety-related conditions. That general role helps explain why it may be prescribed, but it does not determine whether Zoloft is appropriate for an individual or which strength and quantity should be selected.

How does sertraline work and how is it taken?

Sertraline inhibits the reuptake of serotonin, increasing its availability between nerve cells. This action develops quickly at a biochemical level, but improvement in symptoms may take several weeks. A lack of immediate benefit after the first few doses does not by itself show that treatment will be ineffective, and the dose should not be changed without medical guidance.

The tablets are taken by mouth, usually once daily, with or without food, according to the prescribing directions and product leaflet. Taking sertraline at a consistent time can make the routine easier to follow. If it causes sleepiness or difficulty sleeping, a prescriber or pharmacist can advise on whether the timing should be reviewed.

• Follow the prescribed dose and the directions supplied with the medicine.
• Do not take extra tablets to compensate for a missed dose; follow the missed-dose instructions in the leaflet or seek professional advice.
• Do not stop sertraline suddenly unless urgent medical advice requires it. Abrupt discontinuation can cause dizziness, sensory disturbances, sleep problems, agitation, anxiety, nausea or other withdrawal symptoms.
• Do not assume that taking more tablets will produce a faster response.

The full course and any gradual dose reduction should be planned with a prescriber. This is particularly important after longer treatment or when withdrawal symptoms have occurred previously.

Safety, side effects and interactions

Common adverse effects can include nausea, diarrhoea, headache, sleep disturbance, dizziness, dry mouth, increased sweating and sexual difficulties. Effects vary between people, and some improve as treatment continues. Persistent, troublesome or unexpected symptoms should be discussed with a prescriber or pharmacist.

Sertraline must not be used by someone with a known hypersensitivity to sertraline or a tablet ingredient. It is also contraindicated with monoamine oxidase inhibitors (MAOIs), including during the required separation periods around treatment, and with pimozide. Other serotonergic medicines can increase the risk of serotonin syndrome. Anticoagulants, antiplatelet medicines and non-steroidal anti-inflammatory drugs may increase bleeding risk, so a prescriber should know about all prescription medicines, non-prescription products and supplements being used.

Additional considerations include:

• Diabetes: SSRIs can affect glycaemic control. Blood glucose monitoring and adjustment of insulin or other diabetes treatment may be needed.
• Pregnancy: sertraline may be used when a clinician judges treatment necessary, but late-pregnancy exposure has been associated with neonatal adaptation symptoms, persistent pulmonary hypertension of the newborn and a possible increase in bleeding risk around delivery. Treatment should not be stopped abruptly without advice.
• Breastfeeding: sertraline passes into breast milk, although infant blood levels are often very low or undetectable. UK guidance commonly regards it as a preferred SSRI when breastfeeding, but professional assessment and observation of the infant remain appropriate.
• Driving and machinery: the medicine may affect alertness, concentration or physical ability in some people. Do not drive or operate machinery until its effects are known.
• Children and adolescents: careful monitoring is required, particularly for behavioural changes or thoughts of self-harm.

Urgent clinical help is needed for serious reactions, symptoms suggesting serotonin syndrome, severe allergic reactions, seizures, unusual bleeding, or thoughts of suicide or self-harm. Suspected adverse effects can also be reported through the MHRA Yellow Card scheme.

Store the tablets at 25 °C; excursions from 15 °C to 30 °C are permitted. Keep the container tightly closed and protect it from moisture. Follow any additional storage instructions on the supplied packaging.

UK prescription status and our ordering policy

Sertraline tablets are prescription-only medicines (POMs) in the United Kingdom. This classification means that an authorised prescriber must make the clinical decision to prescribe sertraline, including the appropriate dose and treatment duration. The classification applies to the medicine in the UK and is separate from the way our checkout is configured.

Under our current ordering policy for this product, we do not require a customer to upload or submit a prescription document before we accept an order for Zoloft tablets. This statement describes our product-specific ordering requirement; it does not change sertraline's UK classification as a prescription-only medicine and should not be read as clinical approval of a selected strength or quantity.

We do not claim an online-prescription route because none is specified for this service. Customers should already have appropriate medical direction and should seek advice from an authorised prescriber when the intended dose, duration or suitability is uncertain.

Ordering and support

After identifying the prescribed strength, compare the package quantities and prices we display for that strength. Add the selected option to your basket, then review the order total and the payment and delivery information shown at our checkout before submitting the order. This final review can help catch an incorrect strength or quantity before the order is completed.

Our support team is available 24/7 by email, online chat and phone for questions about our product options or an existing order. A pharmacist is also available through our support service for medicine-related questions within the scope of that service. Support does not replace an individual assessment by the prescriber responsible for treatment.

We have operated since 2017. Any applicable delivery choices, charges or destination restrictions should be checked in our checkout rather than assumed from the medicine's UK regulatory status.

Which option offers practical value?

Practical value comes from matching three separate factors: the prescribed strength, a suitable quantity and the total price. The package with the lowest per-tablet cost is not necessarily the most appropriate option if it exceeds the intended supply, spans a planned medication review or is unlikely to be used before expiry.

Use our package comparison to narrow the choice only after confirming the required strength. Then compare the available quantities against the intended treatment period and any forthcoming review. This approach keeps price relevant without allowing a financial calculation to determine the dose or duration of treatment.

If two quantities are both consistent with the authorised supply, the total price, per-tablet value, storage period and likelihood of the full package being used can all inform the decision. When the prescribed quantity or treatment plan is unclear, confirm it with a prescriber or pharmacist before ordering.